Clin2
NCT05906511Possibly a fitRecruiting

Study how THC levels change in older adults

Pain, ToleranceOral vs Vaporized THCAbuse Liability

Treatments studied

Part of Pain clinical trials.

This early study measures how a THC dose (by mouth or vaporized form) moves through the body and how it affects the body’s responses. It mainly looks at safety and how THC behaves in older adults, including people who have used cannabis before.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
20 people
Ages
65 years and older
Study type
Interventional

Who can take part

  • You are age 65 or older
  • You have used THC or cannabis within the last 10 years (frequency depends on the study history)
  • You can read and understand consent paperwork in English
  • You have not had a mental health condition or substance use disorder (other than tobacco) in the past year
  • You are not currently using cannabis/cannabinoid products (urine test must be negative)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06948136Recruiting· Phase 1
THC effects in older adults trial

This trial studies how a single dose of THC (the active ingredient in cannabis) affects older adults. It aims to understand the effects in this age group, which may help guide safe use.

West Haven, Connecticut
NCT02811510Recruiting· Phase 1
Study of THC effects on people with past cannabis use

This Phase 1 study tests how THC (the main active ingredient in cannabis) affects healthy adults, and whether effects differ by gender. It’s designed to learn about short-term body and brain responses to THC.

West Haven, Connecticut
NCT04025359Recruiting· Early Phase 1
Test dronabinol for pain responses in people on opioid treatment

This early-stage study tests whether dronabinol (a form of THC) changes pain perception in people with opioid use disorder who are already stable on methadone or buprenorphine. It may help researchers understand whether this treatment affects pain and drug-related outcomes in a safer, controlled way.

West Haven, Connecticut
NCT02781519Recruiting· Phase 1
Study how THC affects men and women who have used cannabis before

This Phase 1 study tests how delta-9 THC (the main active ingredient in cannabis) affects healthy adults, and whether the effects differ by gender. It may help researchers understand risks and responses to THC, which could guide safer use and future treatments.

West Haven, Connecticut
NCT04704271Recruiting· Phase 1
Study on THC effects in people with past cannabis use

This Phase 1 study looks at how THC (the main mind-altering ingredient in cannabis) affects healthy volunteers shortly after use. It focuses on differences between people and includes those who have used cannabis before.

West Haven, Connecticut
NCT06647524Recruiting· Phase 2
How cannabis affects the aging brain

This study uses brain scans (fMRI) to see how THC (the active ingredient in cannabis) affects the brain as people age. If you are a cannabis user without current dependence or health issues, you may help researchers understand these effects.

Hartford, Connecticut

Hear when a new Pain, Tolerance trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.